Early research (Phase 1)WithdrawnNCT02483871
What this trial is testing
Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Who this might be right for
Breast Cancer
Duke University